Clinical Trials Now Underway In First-Ever Vaccine For The Prevention Of T1D In Humans.

“Clinical trials are underway in the first-ever vaccine for the prevention of type 1 diabetes [T1D] in humans,” researchers from the University of Tampere in Finland have announced. Investigators there have “identified the enteroviruses belonging to the group B coxsackieviruses that are related to diabetes, and” have “developed a prototype vaccine that aims to prevent these viruses.” In the first phase of the clinical trial, safety of the vaccine will be monitored “in a small group of adults.” In the second phase, the vaccine will be evaluated in youngsters. In the third phase, investigators will find out “whether the vaccine could be used to prevent the onset of type 1 diabetes.” http://www.mdmag.com/medical-news/human-trials-begin-on-firstever-preventative-vaccine-for-t1-diabetes-in-humans